Kevin M Klemz Net Worth

The estimated Net Worth of Kevin M Klemz is at least $4.57 Million dollars as of 19 August 2024. Kevin Klemz owns over 2,268 units of Silk Road Medical Inc stock worth over $4,438,104 and over the last 9 years Kevin sold SILK stock worth over $135,286.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Kevin Klemz SILK stock SEC Form 4 insiders trading

Kevin has made over 3 trades of the Silk Road Medical Inc stock since 2023, according to the Form 4 filled with the SEC. Most recently Kevin sold 2,268 units of SILK stock worth $61,463 on 19 August 2024.

The largest trade Kevin's ever made was selling 2,497 units of Silk Road Medical Inc stock on 1 March 2024 worth over $42,873. On average, Kevin trades about 1,051 units every 61 days since 2015. As of 19 August 2024 Kevin still owns at least 162,926 units of Silk Road Medical Inc stock.

You can see the complete history of Kevin Klemz stock trades at the bottom of the page.

What's Kevin Klemz's mailing address?

Kevin's mailing address filed with the SEC is 1213 INNSBRUCK DRIVE, , SUNNYVALE, CA, 94089.

Insiders trading at Silk Road Medical Inc

Over the last 5 years, insiders at Silk Road Medical Inc have traded over $925,682,871 worth of Silk Road Medical Inc stock and bought 14,200 units worth $302,033 . The most active insiders traders include X Finance, L.P.Wpx Gp, L.P...., Pincus & Co.Kaye Charles R ..., and Pincus & Co.Warburg Pincus .... On average, Silk Road Medical Inc executives and independent directors trade stock every 12 days with the average trade being worth of $4,280,712. The most recent stock trade was executed by Kevin M Klemz on 19 August 2024, trading 2,268 units of SILK stock currently worth $61,463.

What does Silk Road Medical Inc do?

silk road medical, inc. is a privately held company located in sunnyvale, california, dedicated to preventing the devastating burden of stroke through surgical innovation. the company develops and manufactures less-invasive medical devices to improve the treatment of vascular disease through proprietary transcarotid therapies. by innovating around proven surgical principles and developing breakthrough technology for vascular specialists, we can improve the lives of people with carotid artery disease. our history is one of deep collaboration with vascular specialists and our future will be guided by continuous learning, observation and improvement. for more information on the company, visit our website at http://silkroadmed.com/. the transcarotid artery revascularization (tcar) procedure is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a stroke. th

Complete history of Kevin Klemz stock trades at Wright Medical NV and Silk Road Medical Inc

Silk Road Medical Inc executives and stock owners

Silk Road Medical Inc executives and other stock owners filed with the SEC include:

• Erica Rogers,
  President, Chief Executive Officer, Director
• Lucas Buchanan,
  Chief Financial Officer, Chief Operating Officer
• Andrew Davis,
  Executive Vice President - Global Sales and Marketing
• Lucas W. Buchanan,
  CFO & COO
• Andrew S. Davis,
  Chief Commercial Officer
• Erica J. Rogers,
  Pres, CEO & Director
• Richard M. Ruedy,
  Exec. VP of Clinical, Regulatory Affairs & Quality Assurance
• Jack Lasersohn,
  Independent Director
• Ruoxi Chen,
  Independent Director
• Donald Zurbay,
  Independent Director
• Elizabeth Weatherman,
  Independent Director
• Tony Chou,
  Independent Director
• Lynn Lewis,
  IR Contact Officer
• Rick Anderson,
  Director
• William Whealon,
  Executive Vice President - Research and Development
• Richard Ruedy,
  Executive Vice President - Regulatory Affairs, Clinical Affairs & Quality Assurance
• Dr. Sumaira MacDonald,
  Exec. Medical Director
• Alison Highlander,
  VP of HR
• Matthew McCarthy,
  VP of Marketing
• William Hill,
  Gen. Counsel
• Mhairi L. Jones,
  VP of Fin. & Accounting
• Kevin M Klemz,
  EVP/Chief Legal Officer/Sec.
• Pincus & Co.Warburg Pincus ...,
  
• John E Runnells,
  
• Richard B Emmitt,
  
• Pincus & Co.Kaye Charles R ...,
  
• Amr Kronfol,
  Director
• Group Lp Vertical,
  
• Venture Partners Xiii, Lp C...,
  
• X Finance, L.P.Wpx Gp, L.P....,
  
• Robert Mittendorff,
  Director
• Pincus & Co.Warburg Pincus ...,
  
• Kevin J. Ballinger,
  
• Tanisha Carino,
  
• Chas Mc Khann,
  Chief Executive Officer
• Marie L. Jones,
  VP, Finance and CAO